Find and Share Events with Friends 🥳
x
2026 Diabetic Lower Extremity Symposium (DLES), Nov 12-13,2026 in Boston, MA promotional image
Company Profile Image

2026 Diabetic Lower Extremity Symposium (DLES), Nov 12-13,2026 in Boston, MA

Conference

What’s Happening?

What is this meeting about?
Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary three day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.

Main objectives:
Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
Discuss new developments in basic, translational and biomaterial research that impact DLE management
Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
Identify possible areas of collaboration between academia and industry

Who should attend this symposium?
Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists)

Scientists and engineers involved in fundamental or translational biomaterial research

R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE

Website https://go.evvnt.com/3631052-2?pid=11150
Website https://go.evvnt.com/3631052-3?pid=11150
Website https://go.evvnt.com/3631052-4?pid=11150
Tickets https://go.evvnt.com/3631052-5?pid=11150
Facebook https://go.evvnt.com/3631052-6?pid=11150
Website https://go.evvnt.com/3631052-7?pid=11150
Inquiries https://go.evvnt.com/3631052-8?pid=11150
Website https://go.evvnt.com/3631052-9?pid=11150
Sponsor https://go.evvnt.com/3631052-10?pid=11150

Prices:
Physician: USD 465.00
RN/Staff: USD 95.00
Fellow/Resident/Student: USD 65.00
PhD/Professor: USD 295.00

Speakers: David Mooney, PhD Boston, MA, Aristidis Veves, MD, DSc Boston, MA, John Giurini, DPM Boston, MA, Allen Hamdan, MD Boston, MA, Osama Hamdy, MD Boston, MA, Teresa Jones, MD Bethesda, MD, Kevin Riemer, DPM Boston, MA, Barry Rosenblum, DPM Boston, MA, Thanh Dinh, DPM, Arriyan S. Dowlatshahi, MD, Cecilia Dupecher, PhD, Abraham Joy, PhD, Mary LaSalvia, MD, Patric Liang, MD, Monika Niewczas, MD, PhD, Marc L. Schermerhorn, MD, Ken Shepard, PhD, Shriya Srinivasan, PhD, Lars Stangenberg, Leonard Tender, PhD, Jim Wu, MD, Mark Wyers, MD, Chandan Sen, PhD, MS, Georgios Theocharidis, PhD

What is this meeting about?
Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary three day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.

Main objectives:
Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
Discuss new developments in basic, translational and biomaterial research that impact DLE management
Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
Identify possible areas of collaboration between academia and industry

Who should attend this symposium?
Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists)

Scientists and engineers involved in fundamental or translational biomaterial research

R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE

Website https://go.evvnt.com/3631052-2?pid=11150
Website https://go.evvnt.com/3631052-3?pid=11150
Website https://go.evvnt.com/3631052-4?pid=11150
Tickets https://go.evvnt.com/3631052-5?pid=11150
Facebook https://go.evvnt.com/3631052-6?pid=11150
Website https://go.evvnt.com/3631052-7?pid=11150
Inquiries https://go.evvnt.com/3631052-8?pid=11150
Website https://go.evvnt.com/3631052-9?pid=11150
Sponsor https://go.evvnt.com/3631052-10?pid=11150

Prices:
Physician: USD 465.00
RN/Staff: USD 95.00
Fellow/Resident/Student: USD 65.00
PhD/Professor: USD 295.00

Speakers: David Mooney, PhD Boston, MA, Aristidis Veves, MD, DSc Boston, MA, John Giurini, DPM Boston, MA, Allen Hamdan, MD Boston, MA, Osama Hamdy, MD Boston, MA, Teresa Jones, MD Bethesda, MD, Kevin Riemer, DPM Boston, MA, Barry Rosenblum, DPM Boston, MA, Thanh Dinh, DPM, Arriyan S. Dowlatshahi, MD, Cecilia Dupecher, PhD, Abraham Joy, PhD, Mary LaSalvia, MD, Patric Liang, MD, Monika Niewczas, MD, PhD, Marc L. Schermerhorn, MD, Ken Shepard, PhD, Shriya Srinivasan, PhD, Lars Stangenberg, Leonard Tender, PhD, Jim Wu, MD, Mark Wyers, MD, Chandan Sen, PhD, MS, Georgios Theocharidis, PhD

When & Where
Nov 12, 2026, 8:00am to
Nov 13, 2026, 5:30pm Timezone: EST
$65.00


More events from EVVNT